DF
LLY icon

Donoghue Forlines’s Eli Lilly LLY Stock Holding History

Donoghue Forlines’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.23M Sell
1,334
-1,499
-53% -$1.52M 0.34% 101
2025
Q4 		$3.04M Buy
+2,833
New +$2.71M 0.94% 13
2025
Q2 		– Sell
-2,737
Closed -$2.26M – 124
2025
Q1 		$2.26M Buy
+2,737
New +$2.28M 0.72% 42
2024
Q1 		– Sell
-2,254
Closed -$1.31M – 249
2023
Q4 		$1.31M Sell
2,254
-139
-6% -$81.1K 0.41% 71
2023
Q3 		$1.29M Sell
2,393
-420
-15% -$216K 0.46% 57
2023
Q2 		$1.32M Sell
2,813
-2,503
-47% -$1.05M 0.41% 53
2023
Q1 		$1.83M Buy
5,316
+89
+2% +$30K 0.66% 23
2022
Q4 		$1.91M Buy
5,227
+791
+18% +$280K 0.68% 25
2022
Q3 		$1.43M Sell
4,436
-4,638
-51% -$1.47M 0.52% 17
2022
Q2 		$2.94M Sell
9,074
-2,862
-24% -$859K 0.77% 17
2022
Q1 		$3.42M Buy
11,936
+366
+3% +$94.2K 0.74% 19
2021
Q4 		$3.2M Sell
11,570
-84
-0.7% -$21.3K 0.54% 26
2021
Q3 		$2.69M Buy
+11,654
New +$2.88M 0.52% 36
2021
Q2 		– Sell
-8,523
Closed -$1.59M – 224
2021
Q1 		$1.59M Buy
8,523
+1,616
+23% +$316K 0.31% 80
2020
Q4 		$1.17M Buy
+6,907
New +$1.03M 0.23% 112
2018
Q4 		– Sell
-153,186
Closed -$16.4M – 95
2018
Q3 		$16.4M Sell
153,186
-59,306
-28% -$5.93M 1.28% 11
2018
Q2 		$18.1M Sell
212,492
-12,113
-5% -$995K 1.5% 11
2018
Q1 		$17.4M Buy
+224,605
New +$18.1M 1.51% 20
2017
Q4 		– Sell
-194,866
Closed -$16.7M – 136
2017
Q3 		$16.7M Sell
194,866
-2,221
-1% -$182K 1.76% 31
2017
Q2 		$16.2M Buy
+197,087
New +$16.1M 1.84% 21

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Donoghue Forlines's LLY Position: Q1 2026 in Review

Donoghue Forlines reduced its Eli Lilly (LLY) stake by 53% in Q1 2026, selling an estimated $1.52M and leaving 1,334 shares worth $1.23M. The position accounts for 0.34% of the portfolio, ranked #101.

Donoghue Forlines first reported a position in LLY in Q2 2017 and has held it in 20 quarters since. The position peaked at $18.1M in Q2 2018. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Donoghue Forlines held 1,334 shares of Eli Lilly worth $1.23M as of Q1 2026.
  • Donoghue Forlines sold 1,499 Eli Lilly shares in Q1 2026, an estimated $1.52M.
  • Eli Lilly made up 0.34% of Donoghue Forlines's portfolio in Q1 2026, its #101 holding.
  • Donoghue Forlines first reported a position in Eli Lilly in Q2 2017 and has held it in 20 quarters since.
  • Donoghue Forlines's Eli Lilly position peaked at $18.1M in Q2 2018.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Donoghue Forlines's 13F filing for Q1 2026, filed 13 May 2026.